Literature DB >> 29287983

Inducible nitric oxide synthase in innate immune cells is important for restricting cyst formation of Toxoplasma gondii in the brain but not required for the protective immune process to remove the cysts.

Qila Sa1, Ashish Tiwari1, Eri Ochiai1, Jeremi Mullins1, Yasuhiro Suzuki2.   

Abstract

Significantly larger numbers of Toxoplasma gondii cysts were detected in the brains of RAG1-/-NOS2-/- than RAG1-/- mice following infection. In contrast, the cyst numbers markedly decreased in a same manner in both strains of mice after receiving CD8+ immune T cells. Thus, NOS2-mediated innate immunity is important for inhibiting formation of cysts in the brain but not required for the T cell-initiated cyst removal, which is associated with phagocyte accumulation. Treatment with chloroquine, an inhibitor of endolysosomal acidification, partially but significantly inhibited the T cell-mediated cyst removal, suggesting that phagosome-lysosome fusion could be involved in the T. gondii cyst elimination.
Copyright © 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CD8(+) T cells; Cyst; Inducible nitric oxide synthase; Phagolysosome; Toxoplasma gondii

Mesh:

Substances:

Year:  2017        PMID: 29287983      PMCID: PMC5911423          DOI: 10.1016/j.micinf.2017.12.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  23 in total

Review 1.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

2.  Ly6C(high) monocytes control cerebral toxoplasmosis.

Authors:  Aindrila Biswas; Dunja Bruder; Susanne A Wolf; Andreas Jeron; Matthias Mack; Markus M Heimesaat; Ildiko Rita Dunay
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

3.  The role of lysosomes in limiting drug toxicity in mice.

Authors:  Rosemary A Ndolo; M Laird Forrest; Jeffrey P Krise
Journal:  J Pharmacol Exp Ther       Date:  2010-01-07       Impact factor: 4.030

Review 4.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

5.  Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.

Authors:  R T Gazzinelli; I Eltoum; T A Wynn; A Sher
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

6.  Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.

Authors:  Yasuhiro Suzuki; Xisheng Wang; Benard S Jortner; Laura Payne; Yanyan Ni; Sara A Michie; Baohui Xu; Tomoya Kudo; Sara Perkins
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

7.  Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.

Authors:  Sascha Martens; Iana Parvanova; Jens Zerrahn; Gareth Griffiths; Gudrun Schell; Gaby Reichmann; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2005-11-18       Impact factor: 6.823

8.  Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages.

Authors:  Yun M Ling; Michael H Shaw; Carol Ayala; Isabelle Coppens; Gregory A Taylor; David J P Ferguson; George S Yap
Journal:  J Exp Med       Date:  2006-08-28       Impact factor: 14.307

9.  Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G S Yap; A Sher
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Christopher Nguyen; Puya G Yazdi; Virginia E Kimonis
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

View more
  7 in total

Review 1.  The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2019-11-25       Impact factor: 2.230

Review 2.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

3.  Penetration of CD8+ Cytotoxic T Cells into Large Target, Tissue Cysts of Toxoplasma gondii, Leads to Its Elimination.

Authors:  Ashish Tiwari; Rancie Hannah; Jenny Lutshumba; Eri Ochiai; Louis M Weiss; Yasuhiro Suzuki
Journal:  Am J Pathol       Date:  2019-07-10       Impact factor: 4.307

Review 4.  A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2020-12-01       Impact factor: 2.230

Review 5.  Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Ahmad Daryani
Journal:  Metab Brain Dis       Date:  2021-09-03       Impact factor: 3.584

6.  Topological integration of RPPA proteomic data with multi-omics data for survival prediction in breast cancer via pathway activity inference.

Authors:  Tae Rim Kim; Hyun-Hwan Jeong; Kyung-Ah Sohn
Journal:  BMC Med Genomics       Date:  2019-07-11       Impact factor: 3.063

7.  Selective Upregulation of Transcripts for Six Molecules Related to T Cell Costimulation and Phagocyte Recruitment and Activation among 734 Immunity-Related Genes in the Brain during Perforin-Dependent, CD8+ T Cell-Mediated Elimination of Toxoplasma gondii Cysts.

Authors:  Jenny Lutshumba; Eri Ochiai; Qila Sa; Namrata Anand; Yasuhiro Suzuki
Journal:  mSystems       Date:  2020-04-14       Impact factor: 6.496

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.